Key Highlights Tezspire (tezepelumab) with no phenotypic (eosinophilic or allergic) or biomarker restriction will be the new game-changer in the severe asthma marketDepemokimab is an excellent mark...
Treatment for pancreatic cancer patients is challenging and not well defined, especially for patients with disease progression or adverse events seen after initial treatment. Studies suggest that, after diagnosis, about 22% of pancreatic cancer patients, regardless of their clinical stage of cancer, receive no trea...
Find More
Currently, there is no cure and no FDA-approved treatments for alopecia. Thus, the alopecia areata treatment market is completely dominated by off-label drug therapies. Depending on the extent of hair loss and age, there are a variety of alopecia areata treatment options are available. The main goal of treatment is...
Find More
Over the past few years, there has been a massive advancement and adoption in the digital health segment. The segment is likely to exhibit growth and onward trend in the coming years as well, owing to the huge capital investment and positive approach by the healthcare authorities Similar, some key factors, such as ...
Find More
WHIM Syndrome possessing limited cures paves the way toward evolving demand for novel treatment therapies. Moreover, the increasing prevalence and R&D activities drive the WHIM syndrome treatment market forward. As per DelveInsight’s latest WHIM Syndrome epidemiology report, there were approximately 180 diag...
Find More
There are a few major unmet needs in the primary sclerosing cholangitis (PSC) treatment market, which include a lack of effective therapies, proven surveillance strategies, tools for early detection of malignancies, impact on quality of life (QoL), and surrogate endpoints in primary sclerosing cholangitis clinical ...
Find More
The rapid growth in technology and innovation are bringing new opportunities and scope for simplification in product development and process and are creating comfort and simplifying lives in their own way. The ongoing breakthroughs and innovation are leading to better outcomes/productivity, saving time, increasing ...
Find More
Acute respiratory distress syndrome (ARDS) is a rapidly progressing condition that affects critically ill people. The major complication of ARDS is fluid leaking into the lungs, which makes breathing difficult or impossible. Shortness of breath, cough, and fever are among ARDS symptoms; in certain cases, high heart...
Find More
Despite decades of research, treatment options are limited in the ARDS market. There are only a few treatments available in the ARDS market. The mainstay of management remains supportive care with mechanical ventilation. Other ARDS treatment options for patients include supplemental oxygen, prone positioning, the u...
Find More
Nanotechnology is an evolving and innovative technology set to transform healthcare dynamics to its core with promising applications. Advancements in nanoscience have led to the emergence of a new generation of nanostructures that are employable in the healthcare industry to a much larger extent. With the unique ab...
Find More
An inflammatory disease of large intestine, Ulcerative Colitis (UC), is approached with therapies th.....
Find More
Age-related macular degeneration (AMD) is an eye disease, which may obscure the simple, central use .....
Find More
Managing patients virtually, the most important healthcare trend of 2020, is a process where healthc.....
Find More
In the past few years, online buying has become the easiest way to purchase products and services. T.....
Find More
Alzheimer's disease is an irreversible, progressive disorder of the brain that progressively destroy.....
Find More
Relapsing-Remitting Multiple Sclerosis (RRMS) is the most common form of Multiple Sclerosis. The ind.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
